Press release
Idiopathic Inflammatory Myopathy Treatment Market Worth $930.6 Million by 2026; Rising Demand for Innovative Therapeutics to Boost Growth: Fortune Business Insights™
The global idiopathic inflammatory myopathy treatment market size is projected to reach USD 930.6 million by 2026, thereby exhibiting a CAGR of 4.6% during the forecast period. However, the market was worth USD 652.3 million in 2018. Fortune Business Insights™ published this information in an upcoming report, titled, “Idiopathic Inflammatory Myopathy Treatment Market Size, Share & Industry Analysis, By Disease Type (Dermatomyositis (DM), Polymyositis (PM), Inclusion Body Myositis (IBM), Necrotizing Autoimmune Myopathy (NAM), Others), By Treatment (Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026.”Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/idiopathic-inflammatory-myopathy-treatment-market-100198
Highlights of the Report:
In-depth analysis of various insights, namely, Idiopathic Inflammatory Myopathy Treatment Market trends, growth drivers, opportunities, and other related challenges.
Comprehensive details of key market players, their core competencies, and Idiopathic Inflammatory Myopathy Treatment Market share.
The potency of suppliers and buyers to make better business decisions.
Lists out the market size in terms of volume.
Key Players Operating in The Idiopathic Inflammatory Myopathy Treatment Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
Grifols, S.A.
ImmunoForge
Shire (Takeda Pharmaceutical Company Limited)
ORPHAZYME A/S
Mylan N.V.
Biotest AG
Pfizer Inc.
CSL Limited (CSL Behring)
LFB Group
Kedrion S.p.A.
Other key market players
Quick Buy
https://www.fortunebusinessinsights.com/checkout-page/100198
Urgent Need for Modern Therapeutics to Boost Growth
Nowadays, numerous new, modern therapies are emerging across the world. The demand for more effective therapeutics is also rising day by day. Earlier, the traditional treatment options had limitations for the doses of immunosuppressants and glucocorticoids. They could be used up to a certain extent. However, today’s innovative therapeutic options help in treating a wide range of myositis.
Moreover, as more and more difficult-to-treat cases of idiopathic inflammatory myopathy increased, mankind realized the dire need for state-of-the-art therapies. It further created a high unmet demand for treatment options. It is expected to be one of the most crucial idiopathic inflammatory myopathy treatment market growth drivers.
Polymyositis Segment to Lead: Rising Prevalence of this Myopathy
By disease type, the market is divided into necrotizing autoimmune myopathy (NAM), dermatomyositis (DM), inclusion body myositis (IBM), polymyositis (PM), and others. Out of these, the PM segment had acquired 44.4% idiopathic inflammatory myopathy treatment market share in 2018. It is expected to retain its leading position throughout the forecast period. It is likely to occur as PM is considered to be one of the highly occurring forms of myositis. It is also capable of causing disability in those people who do not seek medical treatment immediately. Besides, increasing prevalence of PM worldwide and its presence in numerous clinical pipeline by industry giants would propel the growth of this segment. The other segments have also contributed to the steady growth of the market.
Detailed Table of Content:
Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Idiopathic Inflammatory Myopathy by Key Countries, 2018
Advancements in Research & Development of Treatment Options
Pipeline Analysis
Key Industry Developments
New Product Launches
Global Idiopathic Inflammatory Myopathy Treatment Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Disease Type
Dermatomyositis (DM)
Polymyositis (PM)
Inclusion Body Myositis (IBM)
Necrotizing Autoimmune Myopathy (NAM)
Others
Market Analysis, Insights and Forecast – By Treatment
Corticosteroids
Immunosuppressants
Intravenous Immunoglobulins
Others
Market Analysis, Insights and Forecast – By Route of Administration
Oral
Intravenous
Others
Market Analysis, Insights and Forecast – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Analysis, Insights and Forecast – By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
ToC Continue…
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/idiopathic-inflammatory-myopathy-treatment-market-100198
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Inflammatory Myopathy Treatment Market Worth $930.6 Million by 2026; Rising Demand for Innovative Therapeutics to Boost Growth: Fortune Business Insights™ here
News-ID: 2544781 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for Myopathy
X-Linked Myotubular Myopathy (XLMTM) Market to Reach USD 520 Million by 2034
X-Linked Myotubular Myopathy (XLMTM) is a rare, inherited neuromuscular disorder caused by mutations in the MTM1 gene, which disrupts the production of myotubularin. This leads to severe muscle weakness, hypotonia, and respiratory failure, often manifesting in infancy. XLMTM predominantly affects males, with many patients requiring ventilatory support and facing reduced life expectancy.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71707
Although historically limited to supportive care, the XLMTM market is…
Myotubular Myopathy Market Outlook 2032: Emerging Therapies and Future Growth Op …
DelveInsight's "Myotubular Myopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myotubular Myopathy, historical and forecasted epidemiology as well as the Myotubular Myopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover which therapies are expected to grab the Myotubular Myopathy Market Share @ Myotubular Myopathy Market Outlook- https://www.delveinsight.com/sample-request/myotubular-myopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Myotubular Myopathy Market Report
• In March…
Myotubular Myopathy Treatment Market Is Booming Worldwide - Audentes Therapeutic …
Myotubular Myopathy Treatment Market Snapshot
The Myotubular Myopathy Treatment Market is projected to reach USD 0.45 billion by 2030, growing at a CAGR of 15.0% from 2025 to 2032.
Coherent Market Insights proudly presents its latest Myotubular Myopathy Treatment Market Research Report, delivering a detailed examination of the U.S. Myotubular Myopathy Treatment Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving…
Centronuclear Myopathy Pipeline: 5+ Companies Advancing Therapies for Rare Neuro …
The treatment landscape for Centronuclear Myopathy (CNM), a group of rare inherited neuromuscular disorders characterized by muscle weakness and abnormal centralization of nuclei in muscle fibers, is witnessing promising advancements. Driven by growing insights into the genetic basis of the disease and innovative approaches in gene therapy and molecular targeting, several biotech and pharmaceutical companies are actively developing potential treatments. Key players such as Dynacure, Astellas Gene Therapies, and ARMGO…
X-Linked Myotubular Myopathy (XLMTM) Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "X-Linked Myotubular Myopathy (XLMTM) Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Myotubular Myopathy Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Myotubular Myopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Myotubular Myopathy, historical and forecasted epidemiology as well as the Myotubular Myopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
The Myotubular Myopathy market report provides current treatment practices, emerging drugs, the market share of individual therapies, and the current and forecasted Myotubular Myopathy market size…
